多発性骨髄腫に対するダラツムマブ，ボルテゾミブ，デキサメタゾン投与中に進行性多巣性白質脳症を発症した1例-Reference-Cited by-同舟云学术

多発性骨髄腫に対するダラツムマブ，ボルテゾミブ，デキサメタゾン投与中に進行性多巣性白質脳症を発症した1例

Published:2023 Issue:8 Volume:63 Page:513-517
ISSN:0009-918X
Container-title:Rinsho Shinkeigaku
language:en
Short-container-title:Rinsho Shinkeigaku

Author:

Usui Kojiro¹,Kitazaki Yuki¹,Enomoto Soichi¹,Morita Mihoko²,Nakamichi Kazuo³,Hamano Tadanori¹

Affiliation:

1. Department of Neurology, University of Fukui Hospital

2. Department of Hematology and Oncology, University of Fukui Hospital

3. Department of Virology 1, National Institute of Infectious Diseases

Publisher

Societas Neurologica Japonica

Subject

Neurology (clinical)

Link

https://www.jstage.jst.go.jp/article/clinicalneurol/63/8/63_cn-001847/_pdf

Reference15 articles.

1. 1) 進行性多巣性白質脳症（Progressive Multifocal Leukoencephalopathy）診療ガイドライン2020［Internet］．東京：プリオン病及び遅発性ウイルス感染症に関する調査研究班；2020 Mar [cited 2023 Jul 6]. Available from: https://minds.jcqhc.or.jp/docs/gl_pdf/G0001200/4/progressive_multifocal_leukoencephalopathy.pdf.

2. 2) Sanchez L, Wang Y, Siegel DS, et al. Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma. J Hematol Oncol 2016;9:51.

3. 3) Palumbo A, Chanan-Khan A, Weisel K, et al. Daratumumab, Bortezomib, and Dexamethasone for multiple myeloma. N Engl J Med 2016;375:754-766.

4. 4) Monge J, Contreras J, Elsoukkary S, et al. Progressive multifocal leukoencephalopathy in a patient with multiple myeloma receiving daratumumab and pomalidomide. Blood 2019;134:4876.

5. 5) Steinhardt MJ, Wiercinska E, Pham M, et al. Progressive multifocal leukoencephalopathy in a patient post allo-HCT successfully treated with JC virus specific donor lymphocytes. J Transl Med 2020;18:177.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiple drugs;Reactions Weekly;2023-11-18